-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Upgrades RXO to Neutral, Raises Price Target to $30

Benzinga·10/06/2026 12:06:09
Listen to the news
JP Morgan analyst Brian Ossenbeck upgrades RXO (NYSE:RXO) from Underweight to Neutral and raises the price target from $22 to $30.